John Bell

Dr. John Bell is a Professor at the University of Ottawa's Faculty of Medicine and a Cross-Appointed Member at The Ottawa Hospital Research Institute. His research focuses on oncolytic viruses, protein translation, cancer therapeutics, and biochemistry, with a mission to develop novel cancer-killing viruses that selectively target malignant cells while sparing healthy tissue.

• Current position: Senior Scientist (Cancer Research) at OHRI
• Research includes clinical translation and commercialization of therapeutic viruses

His work spans the discovery, design, and manufacturing of oncolytic viruses for cancer treatment. Key research trends include combination immunotherapy, tumor microenvironment interactions, and VEGF signaling in viral targeting, with recent publications emphasizing translational applications and clinical trial frameworks.

Scientific Awards:

• Fellow of the Royal Society of Canada (FRSC)
• Fellow of the Canadian Academy of Health Sciences (FCAHS)

Dr. Bell leads the Bell Lab at OHRI, mentoring researchers in virology and cancer biotherapeutics. His collaborations include clinical trials and industry partnerships in oncolytic virus development.